Srinivas R Viswanathan

12PUBLICATIONS
33CO-AUTHORS
Medical devicesChemotherapyMolecular targetsProteins and peptidesGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 27, 2026
An epigenetic bifunctional that toggles between transactivation and repression.

Ananthan Sadagopan, Maximilian Carson, Eriks J Zamurs

|Dec 19, 2025
BCL-XL Dependence is a Subtype Agnostic Actionable Feature of Difficult-to-Treat Kidney Cancers.

Tupa Basuroy, Treg Grubb, Ananthan Sadagopan

|Nov 12, 2025
Publisher Correction: Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs.

Ananthan Sadagopan, Maximilian Carson, Eriks J Zamurs

|Nov 03, 2025
Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs.

Ananthan Sadagopan, Maximilian Carson, Eriks J Zamurs

|Aug 01, 2025
Dual Inhibition of CDK4/6 and mTORC1 Establishes a Preclinical Strategy for Translocation Renal Cell Carcinoma.

Shikha Gupta, Prateek Khanna, Eddy Saad

|Nov 01, 2024
A framework for target discovery in rare cancers.

Bingchen Li, Ananthan Sadagopan, Jiao Li

Pageof 2